The Journal of Organic Chemistry
Article
allowed to warm to rt, whereupon the white solid dissolved. The
solution was transferred to a 60 mL separatory funnel and diluted with
CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were
separated, and the aqueous layer was extracted with CH2Cl2 (15 mL).
The organic phases were combined, dried over MgSO4, filtered, and
concentrated by rotary evaporation (30 °C, 3 mmHg). The residue
was dissolved in 10 mL of CH2Cl2 and adsorbed onto Celite.
Purification by silica gel flash column chromatography (5:1 hexanes/
CH2Cl2, 20 mm diameter, 16 cm of SiO2) followed by bulb-to-bulb
distillation afforded 308 mg (91%) of 5p as a clear oil. Data for 5p: bp
160 °C (ABT, 0.05 mmHg); 1H NMR: (500 MHz, CDCl3) δ 7.37 (t, J
= 7.7 Hz, 1H, HC(15)), 7.23 (d, J = 7.7 Hz, 2H, HC(14)), 7.17−7.11
(t, J = 7.6 Hz, 1H, HC(7)), 7.09 (d, J = 7.7, 1H, HC(5)), 6.89 (t, J =
7.4, 1H, HC(6)), 6.85 (d, J = 8.3, 1H, HC(8)), 4.16−3.99 (m, 3H,
HC(2), HC(16)), 3.06 (dd, J = 12.9, 6.2 Hz, 1H, HC(11)), 2.92 (dd, J
= 12.9, 6.6 Hz, 1H, HC(11)), 2.90−2.80 (m, 2H, HC(4)), 2.24 (ddd, J
= 13.4, 6.0, 3.7 Hz, 1H, HC(3)), 1.88 (dddd, J = 13.4, 10.7, 9.7, 5.7
Hz, 1H, HC(3)), 1.30 (dd, J = 6.9, 3.9 Hz, 12H, HC(17)); 13C NMR
(101 MHz, CDCl3) δ 154.8 (C12), 153.6 (C9), 131.6 (C4), 129.7
(C7), 129.5 (C14), 127.5 (C5), 124.0 (C10), 122.0 (C13), 120.5
(C6), 117.1 (C8), 74.8 (C2), 42.6 (C11), 31.8 (C3), 27.1 (C4), 24.8
(C17), 24.7 (C17); IR (ATR, cm−1) 3054 (w), 2960 (m), 2924 (m),
2866 (w), 1610 (w), 1582 (m), 1487 (s), 1456 (s), 1420 (w), 1382
(w), 1361 (w), 1339 (w), 1301 (m), 1274 (w), 1232 (s), 1113 (m),
1075 (w), 1050 (s), 1029 (w), 996 (m), 930 (w), 886 (w), 842 (w),
800 (m), 750(s), 710 (w); MS (EI, 70 eV, m/z) 340 (88, M+), 194
(29), 161 (49), 147 (47), 133 (100); TLC Rf 0.61 (1:1, hexanes/
dure 2, 3q (162 mg, 1.0 mmol) was weighed into a dried 10 mL
Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg,
1.0 mmol, 1.0 equiv), and catalyst 2b (52 mg, 0.1 mmol, 0.1 equiv)
were added. The flask was placed in an i-PrOH bath and cooled to 0
°C (probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5
mmol, 0.5 equiv) was added directly via syringe. The solution was
allowed to stir for 48 h at constant temperature during which time
phthalimide precipitated. Upon consumption of the starting material
(TLC, 1H NMR), the reaction was quenched with triethylamine (300
μL) and then was allowed to warm to rt, whereupon the white solid
dissolved. The solution was transferred to a 60 mL separatory funnel
and diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The
phases were separated, and the aqueous layer was extracted with 15
mL of CH2Cl2. The organic phases were combined, dried over MgSO4,
filtered, and concentrated by rotary evaporation (30 °C, 3 mmHg).
Purification by silica gel flash column chromatography (5:1 hexanes/
CH2Cl2, 20 mm diameter, 20 cm of SiO2) followed by bulb-to-bulb
distillation afforded 296 mg (84%) of 5q as a clear, viscous oil. Data for
1
5q: bp 180 °C (ABT, 0.05 mmHg); H NMR (500 MHz, CDCl3) δ
7.34 (t, J = 7.7 Hz, 1H, HC(16)),7.21−7.17 (m, 3H, HC(8),
HC(15)), 7.17−7.12 (m, 2H, HC(6), HC(9)), 7.03 (ddt, J = 8.9, 7.2
Hz, 1H, HC(7)), 4.02 (p, J = 6.8 Hz, 2H, HC(17)), 3.79 (ddd, J =
10.2, 8.0, 4.0 Hz, 1H, HC(2)), 3.15 (dd, J = 12.0 Hz, 8.0 Hz, 1H,
HC(12)), 2.93 (dd, J = 14.4, 12.0 Hz, 1H, HC(5)), 2.74 (ddd, J =
14.9, 12.6, 5.3 Hz, 2H, HC(12), HC(5)), 2.12−1.97 (m, 2H, HC(4),
HC(3)), 1.91−1.79 (m, 1H, HC(3)), 1.60−1.48 (m, 1H, HC(4)) 1.28
(d, J = 6.8 Hz, 6H, HC(18)), 1.23 (d, J = 6.8 Hz, 6H, HC(18)); 13C
NMR (126 MHz, CDCl3) δ 159.1 (C13), 153.5 (C10), 135.8 (C14),
132.3 (C14), 130.3 (C6), 129.3 (C16), 127.6 (C8), 123.9 (C15),
123.8 (C7), 121.9 (C9), 110.0 (C11), 82.6 (C2), 44.7 (C12), 37.0
(C3), 33.9 (C5), 31.8 (C17), 25.9 (C4), 24.7 (C18), 24.6 (C18); IR
(ATR, cm−1) 3055 (w), 2960 (m), 2924 (m), 2865 (w), 1602 (w),
1579 (w), 1487 (s), 1454 (m), 1382 (w), 1360 (m), 1306 (w),
1231(s), 1194 (w), 1178 (w), 1105 (w), 1065 (m), 1052 (m), 1035
(m), 1019 (m), 955 (s), 926 (m), 864 (w), 830 (w), 799 (s), 762 (s),
736 (s), 718 (w); MS (EI, 70 eV, m/z) 354 (82, M+), 194 (100), 160
(81), 153 (51), 151 (51), 107 (98); TLC Rf 0.56 (1:1
23
CH2Cl2) [UV,CAM]; [α]D = +69.7 (c = 1.01 in CHCl3); CD (−),
Cotton sign, 230−280 nm. Anal. Calcd for C22H28OS (340.53): C,
77.60; H, 8.29. Found: C, 77.54; H, 7.93%.
23
Preparation of (R)-2-(((2,6-Diisopropylphenyl)sulfonyl)methyl)-
chromane (S7). To determine enantiomeric composition, 5p was
oxidized to the sulfone. To a 4 dram vial was added solid 5p (20 mg,
0.06 mmol 1 equiv), followed by CH2Cl2 (1 mL) and m-CPBA (26
mg, 0.15 mmol, 2.5 equiv) The solution was stirred at rt for 3 h. The
material was then diluted with hexanes (3 mL) and directly purified by
silica gel flash column chromatography (9:1 hexanes/ethyl acetate, 20
mm diameter, 16 cm of SiO2) to afford 22 mg of a white solid. The
product was analyzed by chiral stationary phase HPLC. Data for S7:
1H NMR (500 MHz, CDCl3) δ 7.53 (t, J = 7.8 Hz, 1H, HC(15)), 7.37
hexanes:CH2Cl2) [UV,CAM]; [α]D = +36.9 (c = 1.1 in CHCl3);
CD, (+), Cotton sign, 230−280 nm. Anal. Calcd for C23H30OS
(354.55): C, 77.92; H, 8.53. Found: C, 77.75; H, 8.25.
(d, J = 7.8 Hz, 2H, HC(14)), 7.01 (d, J = 7.5, 1H, HC(5)), 6.95 (t, J =
7.8 Hz, 1H, HC(7)), 6.81 (t, J = 7.4, 1H, HC(7)), 6.20 (d, J = 8.2, 1H,
HC(8)), 4.77 (dddd, J = 8.8, 7.3, 4.4, 2.7 Hz, 1H, HC(2)), 4.21 (p, J =
6.7 Hz, 2H, HC(16)), 3.74 (dd, J = 14.3, 7.4 Hz, 1H, HC(11)), 3.37
(dd, J = 14.4, 4.4 Hz, 1H, HC(11)), 2.88 (ddd, J = 16.0, 9.5, 6.1 Hz,
1H, HC(4)), 2.77 (dt, J = 16.7, 5.4 Hz, 1H, HC(4)), 2.25 (dddd, J =
13.8, 6.2, 5.1, 2.7 Hz, 1H, HC(3)), 1.90 (dddd, J = 13.5, 9.5, 8.8, 5.7
Hz, 1H, HC(3)), 1.28 (d, J = 6.7 Hz, 6H, HC(17)), 1.23 (d, J = 6.8
Hz, 6H, HC(17)); 13C NMR (126 MHz, CDCl3) δ 153.3, 151.3,
136.2, 133.1, 129.6, 127.6, 126.2, 121.2, 121.0, 117.0, 70.3, 62.4, 29.9,
27.4, 25.2, 25.0, 23.7; CSP-HPLC, (R)-S7 tmaj 8.4 (97.2%), (S)-S7 tmaj
9.0 min (2.8%) (Chiralpak AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8
mL/min).
Preparation of (R)-2-(((2,6-Diisopropylphenyl)sulfonyl)methyl)-
2,3,4,5-tetrahydrobenzo[b]oxepine (S8). To determine enantiomeric
composition, 5q was oxidized to the sulfone. To a 4 dram vial was
added neat 5q (20 mg, 0.06 mmol 1 equiv) followed by CH2Cl2 (1
mL) and m-CPBA (26 mg, 0.15 mmol, 2.5 equiv). The solution was
stirred at rt for 3 h. The material was diluted with hexanes (3 mL) and
then directly purified by silica gel flash column chromatography (9:1
hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) to afford 20
mg of a white solid which was analyzed by chiral stationary phase
1
HPLC. Data for S8: H NMR (500 MHz, CDCl3) δ 7.54 (t, J = 7.8
Hz, 1H, HC(16)), 7.39 (d, J = 7.7 Hz, 2H, HC(15)), 7.08 (d, J = 7.3
Hz, 1H, HC(6)), 7.02 (t, J = 7.6, 1H, HC(8)), 6.96 (t, J = 7.3, 1H,
HC(7)), 6.51 (d, J = 7.8 Hz, 1H, HC(9)), 4.32 (dt, J = 9.0, 3.6, 1H,
HC(2)), 4.22 (p, J = 6.7 Hz, 2H, HC(17)), 3.85 (dd, J = 14.4, 7.1 Hz,
1H, HC(12)), 3.32 (dd, J = 14.3, 3.5 Hz, 1H, HC(12)), 2.94−2.80 (m,
1H, HC(5)), 2.80−2.68 (m, 1H, HC(5)), 2.15−1.90 (m, 3H, HC(3),
HC(4)), 1.72−1.46 (m, 1H, HC(3), HC(4)), 1.30 (d, J = 6.7 Hz, 6H,
HC(18), 1.24 (d, J = 6.7 Hz, 6H, HC(18)); 13C NMR (126 MHz,
CDCl3) δ 158.4, 151.4, 136.0, 135.4, 133.2, 130.2, 127.6, 126.4, 126.4,
124.2, 121.9, 76.8, 64.6, 38.2, 33.6, 29.9, 25.9, 25.3, 24.9; CSP-HPLC,
(S)-S8 tmin 10.5 min (2.3%), (R)-S8 tmaj 11.1 min (97.7%) (Chiralpak
AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min).
Preparation of (R)-2-(((2,6-Diisopropylphenyl)thio)methyl)-
2,3,4,5-tetrahydrobenzo[b]oxepine (5q). Following general proce-
AA
J. Org. Chem. XXXX, XXX, XXX−XXX